Credit: CordenPharma CordenPharma, like most contract progress and manufacturing companies, has kept up its rate so far this 12 months, with only some disruptions. Significantly East operations="" in="" accordance="" with="" the="" regulatory="" versatility="" act,="" fda="" has="" thought o